HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francisca Llinares-Tello Selected Research

Obesity

1/2017Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francisca Llinares-Tello Research Topics

Disease

2Rheumatoid Arthritis
11/2014 - 03/2014
1Obesity
01/2017
1Ankylosing Spondylitis
01/2017
1Rheumatic Diseases (Rheumatism)
01/2016

Drug/Important Bio-Agent (IBA)

3Adalimumab (Humira)FDA Link
01/2017 - 03/2014
1A-factor (Streptomyces)IBA
01/2017
1Infliximab (Remicade)FDA Link
01/2016
1AntibodiesIBA
11/2014

Therapy/Procedure

2Activities of Daily Living (ADL)
01/2017 - 11/2014